Immuno-Oncology 360° Virtual Conference

Memo

The 7th annual IO360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate. The 4 day summit features more than 75 time sensitive IO topics, over 450 senior level thought leaders and includes over 10 hours of networking. Immuno-Oncology 360° Delivers Three Key Benefits:- Access to KOLs driving the science- Partnership opportunities with all stakeholders in Immuno-Oncology- Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology 2021 Plenary Topics- Discovery/Preclinical Science- Cell and Gene Therapy- Translational Science- Bispecifics- Clinical Developments- Neoadjuvant/Adjuvant Data- Emerging Biomarkers- Vaccines- Clinical Operations- AI and Machine Learning- Imaging Advancements- Business Developments Who Should AttendLarge Pharma /Biopharma /Biotech Responsible for:- Cancer Immunotherapy- Immuno-Oncology- R and D Innovation and Strategy- Clinical R and D- Business Development- Preclinical and Translational Research- Licensing and Commercial Strategy- Biomarkers and Companion Dx- Early Stage Collaborations- Clinical Operations- Strategic Partnerships- Medical Affairs- External R and D Investment Community:- Investment Firms- Banks/Financial Institutions- Venture Capitals- Foundation Capital- Analysts Academia and Research Organizations Focusing on:- Immuno-Oncology / Cancer Immunotherapy- Oncology- Immunology- Immunobiology- Cancer Vaccines- Adoptive T-Cell Therapy- Preclinical and Clinical R and D- Biomarkers and Companion Dx Solution Providers:- CROs- Adaptive Trial Design- Diagnostic Testing- Biomarker Software- Data Analysis/Analytics- Logistics- Patient Recruitment- Consultants   Tickets: https://go.evvnt.com/718617-0?pid=5569  Date and Time: On Tuesday February 23, 2021 at 9:00 am (ends Friday February 26, 2021 at 4:00 pm) Prices:Standard Industry: USD 1050.00,Academia, Non-Profit and Government - Final Early Bird: USD 375.00 Speakers: Stewart Abbot, PhD, Andrea Apolo, MD, Carl Barrett, Andrew Baum, MD, Roy Baynes, MD, PhD, David Berman, MD, PhD, Lisa Butterfield, PhD, Jeffrey Bockman, PhD, Chris Cabanski, PhD, Jamie Chaft, MD, Meeta Chatterjee, PhD, Daniel Chen, MD, PhD, Luis Diaz, MD, Ken Drazan, MD, Charles Ferte, MD, PhD, Teresa (Teri) Foy, PhD, Robert Georgantas III, PhD, Gregory Goldmacher, MD, PhD, MBA, Asthika Goonewardene, MBA, Angus Grant, PhD, James Gulley, MD, PhD, Carol Haddad, Omid Hamid, MD, Fred Hassan, MBA, Priti Hegde, PhD, Kristen Hege, MD, Axel Hoos, MD, PhD, Nageatte Ibrahim, MD, Ramy Ibrahim, MD, Julie K Jadlowsky, PhD, Elizabeth Marion Jaffee, PhD, Karin Jooss, PhD, Michael Kalos, PhD, Ron Korn, Theresa LaVallee, PhD, Andy Lee, Israel Lowy, MD, PhD, Yvonne Lu, Jared Lunceford, PhD, Anant Madabhushi, PhD, Anant Madabhushi, PhD, Helen Tayton-Martin, PhD, Elizabeth A Mittendorf, MD, PhD, Dirk Nagorsen, MD, PhD, Andrea Necchi, MD, Haley Neff-LaFord, PhD, Chris Ramsborg, PhD, Vijay Reddy, MD, John Reed, MD, PhD, Naiyer Rizvi, MD, Kole Roybal, PhD, Catherine Sabatos-Peyton, PhD, Michele Sample, MD, Dolores Schendel, PhD, Jeffrey Schlom, PhD, Aiman Shalabi, PharmD, David Shames, PhD, Gary Shapiro, PhD, Padmanee Sharma, MD, PhD, Margaret Shipp, MD, Mark Simon, MBA, Mark Stewart, PhD, Anish Suri, PhD, Weimin Tang, Pascal Touchon, James Trager, PhD, Simon Trowell, Shannon Turley, PhD, Raluca Verona, PhD, Yulei Wang, PhD, Scott Welden, Sapna Yadavilli